Champions Oncology (CSBR) EBIAT (2016 - 2025)
Historic EBIAT for Champions Oncology (CSBR) over the last 16 years, with Q4 2025 value amounting to $268000.0.
- Champions Oncology's EBIAT fell 6318.68% to $268000.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $2.5 million, marking a year-over-year increase of 51170.57%. This contributed to the annual value of $4.7 million for FY2025, which is 16460.97% up from last year.
- Latest data reveals that Champions Oncology reported EBIAT of $268000.0 as of Q4 2025, which was down 6318.68% from -$466000.0 recorded in Q3 2025.
- In the past 5 years, Champions Oncology's EBIAT registered a high of $4.5 million during Q1 2025, and its lowest value of -$2.6 million during Q3 2023.
- Over the past 5 years, Champions Oncology's median EBIAT value was -$245500.0 (recorded in 2021), while the average stood at -$363700.0.
- In the last 5 years, Champions Oncology's EBIAT skyrocketed by 2760000.0% in 2021 and then tumbled by 1284375.0% in 2023.
- Champions Oncology's EBIAT (Quarter) stood at $277000.0 in 2021, then tumbled by 105.78% to -$16000.0 in 2022, then plummeted by 12843.75% to -$2.1 million in 2023, then skyrocketed by 135.15% to $728000.0 in 2024, then crashed by 63.19% to $268000.0 in 2025.
- Its last three reported values are $268000.0 in Q4 2025, -$466000.0 for Q3 2025, and -$1.8 million during Q2 2025.